Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
NF-κB drives epithelial-mesenchymal mechanisms of lung fibrosis in a translational lung cell model
Patrick Sieber, Anny Schäfer, Raphael Lieberherr, Silvia L. Caimi, Urs Lüthi, Jesper Ryge, Jan H. Bergmann, François Le Goff, Manuel Stritt, Peter Blattmann, Bérengère Renault, Patrick Rammelt, Bruno Sempere, Diego Freti, Rolf Studer, Eric S. White, Magdalena Birker-Robaczewska, Maxime Boucher, Oliver Nayler
Patrick Sieber, Anny Schäfer, Raphael Lieberherr, Silvia L. Caimi, Urs Lüthi, Jesper Ryge, Jan H. Bergmann, François Le Goff, Manuel Stritt, Peter Blattmann, Bérengère Renault, Patrick Rammelt, Bruno Sempere, Diego Freti, Rolf Studer, Eric S. White, Magdalena Birker-Robaczewska, Maxime Boucher, Oliver Nayler
View: Text | PDF
Research Article Cell biology Pulmonology

NF-κB drives epithelial-mesenchymal mechanisms of lung fibrosis in a translational lung cell model

  • Text
  • PDF
Abstract

In the progression phase of idiopathic pulmonary fibrosis (IPF), the normal alveolar structure of the lung is lost and replaced by remodeled fibrotic tissue and by bronchiolized cystic airspaces. Although these are characteristic features of IPF, knowledge of specific interactions between these pathological processes is limited. Here, the interaction of lung epithelial and lung mesenchymal cells was investigated in a coculture model of human primary airway epithelial cells (EC) and lung fibroblasts (FB). Single-cell RNA sequencing revealed that the starting EC population was heterogenous and enriched for cells with a basal cell signature. Furthermore, fractions of the initial EC and FB populations adopted distinct pro-fibrotic cell differentiation states upon cocultivation, resembling specific cell populations that were previously identified in lungs of patients with IPF. Transcriptomic analysis revealed active NF-κB signaling early in the cocultured EC and FB, and the identified NF-κB expression signatures were found in “HAS1 High FB” and “PLIN2+ FB” populations from IPF patient lungs. Pharmacological blockade of NF-κB signaling attenuated specific phenotypic changes of EC and prevented FB-mediated interleukin-6, interleukin-8, and CXC chemokine ligand 6 cytokine secretion, as well as collagen α-1(I) chain and α–smooth muscle actin accumulation. Thus, we identified NF-κB as a potential mediator, linking epithelial pathobiology with fibrogenesis.

Authors

Patrick Sieber, Anny Schäfer, Raphael Lieberherr, Silvia L. Caimi, Urs Lüthi, Jesper Ryge, Jan H. Bergmann, François Le Goff, Manuel Stritt, Peter Blattmann, Bérengère Renault, Patrick Rammelt, Bruno Sempere, Diego Freti, Rolf Studer, Eric S. White, Magdalena Birker-Robaczewska, Maxime Boucher, Oliver Nayler

×

Figure 8

Inhibition of c-FOS/AP-1 and IKK/NF-κB affects cocultured epithelial cell population frequencies and marker gene expression at subpopulation resolution.

Options: View larger image (or click on image) Download as PowerPoint
Inhibition of c-FOS/AP-1 and IKK/NF-κB affects cocultured epithelial cel...
(A) Effect of treatment — i.e., 2.5 μM BAY 11-7082 (BAY), 25 μM T-5224 (T5224), and vehicle (veh) — on epithelial lineage cell frequencies (y axis) separated by EC substate and plotted for each time point (t = 0 hours, 3 hours, and 50 hours; x axis). (B) Effect of the NF-κB inhibitor BAY 11-7082 (2.5 μM) applied from t = 0 hours, on enriched canonical pathways (CP, Reactome) in the EC DEGs at time t = 3 hours displayed as bars representing the –log10(FDR). (C) Violin plots displaying the expression level of KRT5, KRT14, KRT17, KRT18, KRT19, TP63, SOX9, COL1A1, TGFB1, CCN2, ELN, ACTA2, SOX4, and HES4, separated by sample and at the level of the subclustered cell state identifier EC_COL1A2. Cells were either untreated (vehicle) or treated (i.e., 2.5 μM BAY 11-7082, 25 μM T-5224) and collected in a single experiment at the time points (t = 0 hours, 3 hours, and 50 hours). Normalized gene expression is depicted as log(counts+1) for a nonstatistical overview of gene-of-interest expression in the data set.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts